Longeveron Inc. (LGVN)
NASDAQ: LGVN
· Real-Time Price · USD
1.39
-0.05 (-3.47%)
At close: May 14, 2025, 3:59 PM
1.41
1.44%
After-hours: May 14, 2025, 06:00 PM EDT
-3.47% (1D)
| Bid | 1.36 |
| Market Cap | 20.86M |
| Revenue (ttm) | 2.23M |
| Net Income (ttm) | -16.92M |
| EPS (ttm) | -2.62 |
| PE Ratio (ttm) | -0.53 |
| Forward PE | -1.1 |
| Analyst | Buy |
| Ask | 1.44 |
| Volume | 60,264 |
| Avg. Volume (20D) | 254,891 |
| Open | 1.41 |
| Previous Close | 1.44 |
| Day's Range | 1.34 - 1.43 |
| 52-Week Range | 0.77 - 6.40 |
| Beta | 0.37 |
About LGVN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LGVN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LGVN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-0.65%
Longeveron shares are trading higher after the com...
Unlock content with
Pro Subscription
9 months ago
+0.87%
Longeveron shares are trading higher after the company announced study results from the CLEAR MIND Phase 2a clinical trial of Lomecel-B in mild Alzheimer's disease, meeting its key objectives to advance data supporting a favorable benefit/risk profile.
